Genitourinary Cancer

Latest News

Career Development
The Transition from Being an Oncology Nurse in Breast Cancer to an Advanced Practice Nurse in GU Oncology

January 3rd 2024

Overall, the transition from breast to genitourinary cancer has added depth and dimension to my knowledge of cancer care.

kidney cancer
12-Week Dosing Schedule for Ipilimumab/Nivolumab May Reduce Grade 3-5 TRAEs in Advanced RCC

December 29th 2023

prostate cancer
PROfound Trial Subgroup Analysis Finds Consistent Olaparib Benefit for mCRPC With BRCA Alterations

December 28th 2023

FDA
FDA Approves Belzutifan for Patients With Advanced Renal Cell Carcinoma

December 14th 2023

prostate cancer
Nurse Practitioners Discuss AE Management With Prostate Cancer Treatments

December 12th 2023

Latest CME Events & Activities

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

Miami Breast 2024: Affiliated CE Symposia

March 7, 2024 - March 9, 2024

View More

Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond

View More

A Focus on Acute Myeloid Leukemia

View More

The Latest on Acute Lymphocytic Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

8th Annual School of Nursing Oncology™

August 10, 2024

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2024 MJH Life Sciences

All rights reserved.